208 related articles for article (PubMed ID: 27934159)
1. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.
Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP
ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159
[TBL] [Abstract][Full Text] [Related]
2. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.
Näkki S; Rytkönen J; Nissinen T; Florea C; Riikonen J; Ek P; Zhang H; Santos HA; Närvänen A; Xu W; Lehto VP
Acta Biomater; 2015 Feb; 13():207-15. PubMed ID: 25463492
[TBL] [Abstract][Full Text] [Related]
3. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.
Sarparanta M; Bimbo LM; Rytkönen J; Mäkilä E; Laaksonen TJ; Laaksonen P; Nyman M; Salonen J; Linder MB; Hirvonen J; Santos HA; Airaksinen AJ
Mol Pharm; 2012 Mar; 9(3):654-63. PubMed ID: 22277076
[TBL] [Abstract][Full Text] [Related]
4. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with
Jakobsson U; Mäkilä E; Rahikkala A; Imlimthan S; Lampuoti J; Ranjan S; Heino J; Jalkanen P; Köster U; Mizohata K; Santos HA; Salonen J; Airaksinen AJ; Sarparanta M; Helariutta K
Nucl Med Biol; 2020; 84-85():102-110. PubMed ID: 32334356
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Fluorescence Imaging and Elemental Analysis to Determine Biodistribution of Inorganic Nanoparticles with Strong Light Absorption.
Tamarov K; Wang JT; Kari J; Happonen E; Vesavaara I; Niemelä M; Perämäki P; Al-Jamal KT; Xu W; Lehto VP
ACS Appl Mater Interfaces; 2021 Sep; 13(34):40392-40400. PubMed ID: 34405988
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulation.
Konduru NV; Murdaugh KM; Swami A; Jimenez RJ; Donaghey TC; Demokritou P; Brain JD; Molina RM
Nanotoxicology; 2016 Aug; 10(6):720-7. PubMed ID: 26581431
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
[TBL] [Abstract][Full Text] [Related]
10. A Systematic comparison of in vitro cell uptake and in vivo biodistribution for three classes of gold nanoparticles with saturated PEG coatings.
Zhang Y; Liu AT; Cornejo YR; Van Haute D; Berlin JM
PLoS One; 2020; 15(7):e0234916. PubMed ID: 32614882
[TBL] [Abstract][Full Text] [Related]
11. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
12. Coating nanoparticles with tunable surfactants facilitates control over the protein corona.
Müller J; Bauer KN; Prozeller D; Simon J; Mailänder V; Wurm FR; Winzen S; Landfester K
Biomaterials; 2017 Jan; 115():1-8. PubMed ID: 27871002
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
[TBL] [Abstract][Full Text] [Related]
14. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
15. Hydrophilicity Regulates the Stealth Properties of Polyphosphoester-Coated Nanocarriers.
Simon J; Wolf T; Klein K; Landfester K; Wurm FR; Mailänder V
Angew Chem Int Ed Engl; 2018 May; 57(19):5548-5553. PubMed ID: 29479798
[TBL] [Abstract][Full Text] [Related]
16. Amphoteric natural starch-coated polymer nanoparticles with excellent protein corona-free and targeting properties.
Huang B; Yang Z; Fang S; Li Y; Zhong Z; Zheng R; Zhang J; Wang H; Wang S; Zou Q; Wu L
Nanoscale; 2020 Mar; 12(10):5834-5847. PubMed ID: 32068222
[TBL] [Abstract][Full Text] [Related]
17. In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy.
Li Z; Li D; Li Q; Luo C; Li J; Kou L; Zhang D; Zhang H; Zhao S; Kan Q; Liu J; Zhang P; Liu X; Sun Y; Wang Y; He Z; Sun J
Biomater Sci; 2018 Sep; 6(10):2681-2693. PubMed ID: 30151516
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
Larsen EK; Nielsen T; Wittenborn T; Rydtoft LM; Lokanathan AR; Hansen L; Østergaard L; Kingshott P; Howard KA; Besenbacher F; Nielsen NC; Kjems J
Nanoscale; 2012 Apr; 4(7):2352-61. PubMed ID: 22395568
[TBL] [Abstract][Full Text] [Related]
19. Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.
Im HJ; England CG; Feng L; Graves SA; Hernandez R; Nickles RJ; Liu Z; Lee DS; Cho SY; Cai W
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17955-63. PubMed ID: 27340833
[TBL] [Abstract][Full Text] [Related]
20. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
